The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV has been updated by the National Institutes of Health, the HIV Medicine Association, and the Infectious Diseases Society of America. The document is published in an electronic format and updated as relevant changes in prevention and treatment recommendations occur.
As of November 12, 2024, the following guidelines’ updates for immunizations include:
- Updated COVID-19 and influenza recommendations with new information on current vaccine formulations and data supporting their use.
- Provided new recommendations for the use of respiratory syncytial virus (RSV) vaccines including data supporting their use.
- Updated HepBCpG (Heplisav-B) to the preferred hepatitis B vaccine for people with HIV.
- Added pentavalent meningococcal conjugate vaccine (MenABCWY) recommendations as an alternative to separate administration of quadrivalent meningococcal vaccine and meningococcal group B vaccine.